Baxter International Cash Flow Statement
NYSE: BAXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Baxter International free cash flow
In fiscal 2025, Baxter International generated $845.0 million of operating cash flow and spent $513.0 million on capital expenditures. That left free cash flow of $332.0 million, a free-cash-flow margin of 3.0% of revenue. Free cash flow was down 42.1% from the prior year's $573.0 million.
Baxter International returned $348.0 million to shareholders through dividends, equal to 105% of free cash flow. Free cash flow covered dividend payments 1.0 times.
Summary generated from market data by MetaCap's automated system. Methodology
Baxter International cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -957.00M | -638.00M | 2.66B | -2.42B | 1.29B | 1.11B | 1.01B | 1.55B | 602.00M | 4.96B |
| Net Income growth (YoY) | — | -123.96% | — | -286.95% | +16.67% | +9.79% | -34.61% | +156.81% | -87.88% | +412.91% |
| Depreciation & Amortization | 981.00M | 997.00M | 984.00M | 1.07B | 867.00M | 823.00M | 789.00M | 771.00M | 750.00M | 800.00M |
| Stock-Based Compensation | 117.00M | 114.00M | 115.00M | 140.00M | 146.00M | 130.00M | 122.00M | 115.00M | 107.00M | 115.00M |
| Change in Working Capital | -176.00M | -249.00M | -119.00M | -630.00M | -19.00M | -175.00M | -298.00M | -149.00M | 117.00M | -102.00M |
| Operating Cash Flow | 845.00M | 1.02B | 1.73B | 1.21B | 2.22B | 1.87B | 2.10B | 2.02B | 1.71B | 1.65B |
| Capital Expenditures | -513.00M | -446.00M | -432.00M | -377.00M | -691.00M | -709.00M | -696.00M | -659.00M | -616.00M | -719.00M |
| Investing Cash Flow | 2.84B | -626.00M | 3.21B | -931.00M | -11.20B | -1.18B | -1.10B | -916.00M | -1.29B | -715.00M |
| Dividends Paid | -348.00M | -590.00M | -586.00M | -573.00M | -530.00M | -473.00M | -423.00M | -376.00M | -315.00M | -268.00M |
| Share Repurchases | — | 0 | 0 | -32.00M | -600.00M | -500.00M | -1.27B | -2.45B | -564.00M | -292.00M |
| Debt Issued | 2.00B | 0 | 0 | 0 | 11.90B | 1.89B | 1.66B | 0 | 665.00M | 1.64B |
| Debt Repaid | -5.49B | -2.66B | -2.63B | -954.00M | -2.82B | -1.18B | 0 | 0 | -1.00M | -1.38B |
| Financing Cash Flow | -4.22B | -1.08B | -3.49B | -1.44B | 8.24B | -345.00M | 498.00M | -2.60B | 93.00M | -324.00M |
| Net Change in Cash | -446.00M | -784.00M | 1.48B | -1.23B | -780.00M | 401.00M | 1.50B | -1.56B | 617.00M | 588.00M |
| Free Cash Flow | 332.00M | 573.00M | 1.29B | 834.00M | 1.53B | 1.16B | 1.41B | 1.36B | 1.10B | 935.00M |
This table shows 10 annual periods of Baxter International's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow BAX's reporting calendar. What is a cash flow statement?